About 7 times higher sensitivity compared to RNA-seq! Accurately identifies transcription start sites without PCR. *A free booklet titled "Differences in Gene Expression Analysis Methods" is currently available.
We offer a contract analysis service using the technology 'CAGE' to quantitatively analyze the expression of mRNA and ncRNA at each transcription start site. It has approximately seven times the detection sensitivity compared to RNA-seq analysis, and because it is PCR-free, it excels in quantitativeness, providing comprehensive expression data. We provide thorough support for the analysis. The delivered data includes standard sets for expression levels, expression comparisons, clustering, and more. Quality checks of sample RNA and data analysis are part of the basic service, with no additional costs. This service is also recommended for first-time users or those concerned about data analysis. 【Features】 ■ Jointly developed technology with RIKEN ■ Genome-wide quantitative analysis of transcription start sites ■ Comprehensive expression analysis not only of genes but also of promoters ■ Enables exploration of gene expression networks at the promoter level ■ Standard implementation of transcription factor binding motif exploration ■ The price is approximately 100,000 yen per sample, including analysis *For more details about the product, please refer to the PDF document below. *You can also download the booklet "Differences in Gene Expression Analysis Methods as Seen in FAQs" for free from the link below.
Inquire About This Product
basic information
【Other Features】 ◎ Acquires approximately 20 million reads of data per sample with 75 bp single-end sequencing ◎ The analysis package includes quality inspection of sample RNA, library preparation, sequencing, data analysis, and data delivery ◎ Library preparation is done using the cap-trapper method ◎ NGS sequencing is performed using Illumina NextSeq/HiSeq ◎ Sequences 75 bases from the 5' end of RNA 【Applications】 ◎ Gene expression analysis ◎ Discovery of novel biomarkers ◎ Measurement of expression changes due to drugs or environmental changes ◎ Construction of transcriptome databases ◎ Comparative analysis of transcripts across varieties, tissues, and disease states, etc. *For more details, please refer to the materials. Feel free to contact us with any inquiries.
Price range
P2
Delivery Time
※4-6 weeks
Applications/Examples of results
*For more details, please refer to the materials. Feel free to contact us as well.*
catalog（8）
Download All Catalogs
Company information
Danaform Inc. is a company established in 1998, based on the RIKEN Venture System of the National Research and Development Agency RIKEN, with Yoshihide Hayasaki from RIKEN (who has been the representative director of Danaform Inc. since 2021) at its core. The company is actively engaged in gene analysis and genetic testing, focusing on technologies co-developed by Danaform and RIKEN, including contract analysis using next-generation sequencers such as CAGE-seq and RNA-seq, the sale of fluorescent reagents Eprobe capable of SNP detection, and the sale of various clones, boasting a significant inventory. Moving forward, we aim to refine our proprietary technologies and strive for higher quality research and manufacturing as experts in the field of genetics, with the hope of contributing to people's health.